The global aortic valve replacement devices market size is expected to reach USD 12.76 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.
Widening base of geriatric population is one of the key growth stimulants. As per data published by Medicare and Medicaid services, the number of aortic stenosis patients over 65 years of age is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis coupled with improving treatment rates is expected to bolster the growth of the market over the forecast period. In addition, growing preference for minimally invasive surgeries is escalating the growth of the market. These procedures cause lesser trauma to patient along with better outcomes and facilitate faster recovery than conventional open-heart surgeries. MIS requires relatively lesser number of hospital stays and is hence economically more viable than conventional invasive surgeries.
Favorable reimbursement policies are one of the crucial factors anticipated to drive the market in the near future. Centers for Medicare & Medicaid Services (CMS) announced that it would provide coverage for TAVR under the Medicare National Coverage Determination policy. Moreover, increasing number of clinical studies undertaken by key players for extending interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives is also working in favor of the market. However, product recalls due to safety concerns are projected to inhibit the growth of the market.
Request a free sample copy or view report summary: Aortic Valve Replacement Devices Market Report
Balloon-expandable valves dominated the market with a revenue share of 68.7% in 2024. Balloon-expandable valves are increasingly preferred due to their lower risk of valve migration and reliable outcomes.
The bovine pericardium segment led the market with a revenue share of 72.5% in 2024, owing to its superior mechanical properties and biocompatibility.
Cobalt-chromium frames held the largest market share of 64.0% in 2024 and exhibit exceptional mechanical properties, including strength, durability, and corrosion resistance, making them ideal for TAVR device construction.
Inpatient facilities dominated the market and accounted for a share of 92.2% in 2024. Hospitals and clinics are equipped with advanced medical infrastructure, skilled personnel, and essential post-operative monitoring to manage potential complications from aortic valve surgeries.
North America aortic valve replacement devices market dominated the global market with a revenue share of 59.7% in 2024. North America boasts advanced healthcare infrastructure, a high prevalence of aortic stenosis, and substantial investments in medical technology.
Grand View Research has segmented the global aortic valve replacement devices market on the basis of on product, leaflet material, frame material, end-use, and region:
Aortic Valve Replacement Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Balloon-expandable
Self-expandable
Mechanically Expandable
Aortic Regurgitation
Aortic Valve Replacement Devices Leaflet Material Outlook (Revenue, USD Million, 2018 - 2030)
Bovine Pericardium
Porcine Pericardium
Aortic Valve Replacement Devices Frame Material Outlook (Revenue, USD Million, 2018 - 2030)
Cobalt-Chromium
Nitinol
Others
Aortic Valve Replacement Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Inpatient Facilities
Outpatient Facilities
Aortic Valve Replacement Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Aortic Valve Replacement Devices Market
Boston Scientific Corporation
Artivion, Inc
Edwards Lifesciences Corporation
LivaNova PLC
Medtronic
Abbott
"The quality of research they have done for us has been excellent..."